Abstract
Molecular diagnostics is progressing from low-throughput, heterogeneous, mostly manual technologies to higher throughput, closed-tube, and automated methods. Fluorescence is the favored signaling technology for such assays, and a number of techniques rely on energy transfer between a fluorophore and a proximal quencher molecule. In these methods, dual-labeled probes hybridize to an amplicon and changes in the quenching of the fluorophore are detected. We describe a new technology that is simple to use, gives highly specific information, and avoids the major difficulties of the alternative methods. It uses a primer with an integral tail that is used to probe an extension product of the primer. The probing of a target sequence is thereby converted into a unimolecular event, which has substantial benefits in terms of kinetics, thermodynamics, assay design, and probe reliability.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ishiguro, T. et al. Homogeneous quantitative assay of hepatitis C virus RNA by polymerase chain reaction in the presence of a fluorescent intercalater. Anal. Biochem. 229, 207–213 (1995).
Tseng, S.Y. et al. An homogeneous fluorescence polymerase chain reaction assay to identify Salmonella. Anal. Biochem. 245, 207–212 (1997).
Wittwer, C.T. et al. The LightcyclerTM a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22, 176–181 (1997).
Wittwer, C.T., Herrmann, M.G., Moss, A.A. & Rasmussen, R.P. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 22, 130. (1997).
Nazarenko, I.A., Bhatnagar, S.K. & Hohman, R.J. A closed tube format for amplification and detection of DNA based on energy transfer. Nucleic Acids Res. 25, 2516–2521 (1997).
Brownie, J. et al. The elimination of primer-dimer accumulation in PCR. Nucleic Acids Res. 25, 3235–3241 (1997).
Gibson, N. J. et al. A homogeneous method for genotyping with fluorescence polarization. Clin. Chem. 43, 1336–1341 (1997).
Holland, P.M., Abramson, R.D., Watson, R. & Gelfand, D.H. Detection of specific polymerase chain reaction product by utilizing the 5'–3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA 88, 7276– 7280 (1991).
Gelmini, S. et al. Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure C-Erbb-2 oncogene amplification. Clin. Chem. 43, 752–758 (1997).
Livak, K.J., Marmaro, J. & Todd, J.A. Towards fully automated genome-wide polymorphism screening. Nat. Genet. 9, 341–342 (1995).
Tyagi, S. & Kramer, F.R. Molecular beacons—probes that fluoresce upon hybridization. Nat. Biotechnol. 14, 303–308 (1996).
Tyagi, S., Bratu, D.P. & Kramer, F.R. Multicolor molecular beacons for allele discrimination. Nat. Biotechnol. 16, 49– 53 (1998).
Newton, C.R. et al. The production of PCR products with 5´ single-stranded tails using primers that incorporate novel phosphoramidite intermediates. Nucleic Acids Res. 21, 1155– 1162 (1993).
Ibrahim, M.S., Esposito, J.J., Jahrling, P.B. & Lofts, R.S. The potential of 5´ nuclease PCR for detecting a single-base polymorphism in orthopoxvirus. Mol. Cell. Probes 11, 143–147 (1997).
Ibrahim, M.S. et al. Real-time microchip PCR for detecting single-base differences in viral and human DNA. Anal. Chem. 70, 2013–2017 (1998).
Couch, F. J. et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat. Genet. 13, 123– 125 (1996).
Ferrie, R.M., Ellison, G., Callaghan, K. & Fox, J.C. UK Patent Application, number 9815224.2 ( 1998).
van den Velden, P.A. & Reitsma, P.H. Amino acid dimorphism in IL1A is detectable by PCR amplification; Hum. Mol. Genet. 2, 1753 (1993).
Zuker, M. mfold Program website. http://www.ibc.wustl.edu/~zuker.
Santalucia, J. A unified view of polymer, dumbbell, & oligonucleotide DNA nearest-neighbor thermodynamics. Proc. Natl. Acad. Sci. USA 95, 1460–1465 (1998).
Newton, C.R. et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 17, 2503–2516 (1989).
Ferrie, R.M. et al. Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene. Am. J. Hum. Genet. 51, 251–262 (1992).
Acknowledgements
We thank Dr. Neil Gibson for helpful discussions, Kay Callaghan and Kemal Haque for sharing of unpublished K-ras data, and Dr. Julian Sorrell for information concerning IL-1A polymorphisms. The methods described in this paper form part of worldwide patent applications. ARMS is the subject of European patent number 0332435 (ZENECA Ltd.) and corresponding US patent #5595890. The use of nonamplifiable tails and blocking monomers are the subjects of European patent 0416817 (ZENECA Ltd.) and corresponding US patent #5525494.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Whitcombe, D., Theaker, J., Guy, S. et al. Detection of PCR products using self-probing amplicons and fluorescence . Nat Biotechnol 17, 804–807 (1999). https://doi.org/10.1038/11751
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/11751
This article is cited by
-
Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays
Nature Communications (2022)
-
A cost-effective and efficient approach for generating and assembling reagents for conducting real-time PCR
Journal of Biosciences (2021)
-
High throughput single cell analysis of mitochondrial heteroplasmy in mitochondrial diseases
Scientific Reports (2020)
-
Development and validation of high-throughput and low-cost STARP assays for genes underpinning economically important traits in wheat
Theoretical and Applied Genetics (2020)
-
CMAB009 plus irinotecan versus irinotecan‐only as second‐line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild‐type metastatic colorectal cancer patients: promising findings from a prospective, open‐label, randomized, phase III trial
Cancer Communications (2019)